Tenon Medical, Inc.(TNON)
$1.06-0.19 (-15.20%)
TNON
Tenon Medical, Inc. financials statements
$1.06
At close:-0.19 (-15.20%)
Want to see TNON full AI Analyst Report?
Tenon Medical, Inc. (TNON) Ratios
339 Followers
Tenon Medical, Inc. Ratios
TNON's free cash flow for Q2 2026 was $-2.93M. For the 2026 fiscal year, TNON's free cash flow was decreased by $-172.00K and operating cash flow was $-2.76M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.11 | 4.39 | 1.24 | 3.69 | 0.50 |
| Quick Ratio | 1.78 | 4.07 | 1.06 | 3.53 | 0.49 |
| Cash Ratio | 1.17 | 3.50 | 0.77 | 0.84 | 0.19 |
| Solvency Ratio | -2.10 | -3.36 | -2.72 | -3.85 | -0.23 |
| Operating Cash Flow Ratio | -3.34 | -5.29 | -3.88 | -4.75 | -0.28 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -10.39 | -52.74 | -0.32 |
| Net Current Asset Value | $ 1.05M | $ 4.34M | $ -1.68M | $ 4.51M | $ -22.15M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.04 | 0.29 | 0.08 | 1.58 |
| Debt-to-Equity Ratio | 0.03 | 0.07 | 2.39 | 0.15 | -0.71 |
| Debt-to-Capital Ratio | 0.03 | 0.07 | 0.70 | 0.13 | -2.46 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.13 | 1.65 | 8.16 | 1.77 | -0.45 |
| Debt Service Coverage Ratio | 0.00 | -381.88 | -12.68 | -31.40 | -0.45 |
| Interest Coverage Ratio | 0.00 | -404.88 | -748.90 | -52.90 | -10.40 |
| Debt to Market Cap | 0.00 | 0.00 | 0.41 | 0.02 | 0.66 |
| Interest Debt Per Share | 0.67 | 0.38 | 8.27 | 12.52 | 1350.11 |
| Net Debt to EBITDA | 0.30 | 0.47 | 0.04 | 0.07 | -1.84 |
| Profitability Margins | |||||
| Gross Profit Margin | 59.79% | 52.21% | 42.38% | -92.76% | 65.63% |
| EBIT Margin | -318.36% | -416.20% | -531.42% | -2686.40% | -4037.50% |
| EBITDA Margin | -304.92% | -396.22% | -516.87% | -2644.57% | -3966.25% |
| Operating Profit Margin | -324.34% | -420.08% | -537.12% | -2709.84% | -4038.13% |
| Pretax Profit Margin | -318.36% | -417.24% | -532.14% | -2737.63% | -4425.63% |
| Net Profit Margin | -318.36% | -417.24% | -532.14% | -2737.63% | -4405.00% |
| Continuous Operations Profit Margin | -318.36% | -417.24% | -532.14% | -2737.63% | -4425.63% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 99.53% |
| EBT Per EBIT | 98.16% | 99.32% | 99.07% | 101.03% | 109.60% |
| Return on Assets (ROA) | -116.69% | -138.91% | -245.56% | -170.59% | -76.01% |
| Return on Equity (ROE) | -249.13% | -228.99% | -2002.70% | -302.58% | 34.29% |
| Return on Capital Employed (ROCE) | -169.50% | -172.64% | -490.70% | -218.78% | 107.65% |
| Return on Invested Capital (ROIC) | -166.39% | -166.64% | -339.38% | -213.10% | -83.84% |
| Return on Tangible Assets | -159.58% | -138.91% | -245.56% | -170.59% | -76.01% |
| Earnings Yield | -178.72% | -599.08% | -543.03% | -148.18% | -34.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.32 | 3.80 | 5.57 | 2.87 | 2.11 |
| Payables Turnover | 1.88 | 4.24 | 3.90 | 2.42 | 0.12 |
| Inventory Turnover | 1.50 | 2.58 | 3.05 | 3.21 | 0.29 |
| Fixed Asset Turnover | 3.76 | 2.85 | 1.82 | 0.41 | 0.14 |
| Asset Turnover | 0.37 | 0.33 | 0.46 | 0.06 | 0.02 |
| Working Capital Turnover Ratio | 0.80 | 0.92 | 0.77 | -1.76 | -0.04 |
| Cash Conversion Cycle | 205.24 | 151.36 | 91.75 | 90.31 | -1751.17 |
| Days of Sales Outstanding | 157.14 | 96.12 | 65.57 | 127.30 | 173.38 |
| Days of Inventory Outstanding | 242.57 | 141.25 | 119.86 | 113.72 | 1247.64 |
| Days of Payables Outstanding | 194.47 | 86.01 | 93.68 | 150.71 | 3172.18 |
| Operating Cycle | 399.71 | 237.37 | 185.43 | 241.02 | 1421.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -50.93 | -8.14 | -53.67 | -119.06 | -380.23 |
| Free Cash Flow Per Share | -52.23 | -8.29 | -55.26 | -127.45 | -389.26 |
| Dividend Paid and CapEx Coverage Ratio | -39.36 | -53.11 | -33.75 | -14.20 | -42.08 |
| Capital Expenditure Coverage Ratio | -39.36 | -53.11 | -33.75 | -14.20 | -42.08 |
| Operating Cash Flow Coverage Ratio | -76.21 | -23.08 | -6.56 | -13.20 | -0.29 |
| Operating Cash Flow to Sales Ratio | -2.72 | -3.01 | -4.16 | -17.40 | -26.82 |
| Free Cash Flow Yield | -156.83% | -440.95% | -437.18% | -100.83% | -21.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.56 | -0.17 | -0.18 | -0.67 | -2.88 |
| Price-to-Sales (P/S) Ratio | 1.78 | 0.70 | 0.98 | 18.48 | 126.99 |
| Price-to-Book (P/B) Ratio | 1.39 | 0.38 | 3.69 | 2.04 | -0.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.64 | -0.23 | -0.23 | -0.99 | -4.62 |
| Price-to-Operating Cash Flow Ratio | -0.65 | -0.23 | -0.24 | -1.06 | -4.73 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.00 | 0.00 | 0.01 | -0.00 |
| Enterprise Value Multiple | -0.28 | 0.29 | -0.15 | -0.63 | -5.05 |
| Enterprise Value | 3.41M | -3.82M | 2.30M | 11.55M | 32.02M |
| EV to EBITDA | -0.28 | 0.29 | -0.15 | -0.63 | -5.05 |
| EV to Sales | 0.86 | -1.17 | 0.78 | 16.71 | 200.13 |
| EV to Free Cash Flow | -0.31 | 0.38 | -0.18 | -0.90 | -7.29 |
| EV to Operating Cash Flow | -0.32 | 0.39 | -0.19 | -0.96 | -7.46 |
| Tangible Book Value Per Share | 10.18 | 4.92 | 3.43 | 61.90 | -1820.69 |
| Shareholders’ Equity Per Share | 23.89 | 4.92 | 3.43 | 61.90 | -1820.69 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 18.69 | 2.70 | 12.90 | 6.84 | 14.17 |
| Net Income Per Share | -59.52 | -11.26 | -68.64 | -187.30 | -624.38 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.02 | 1.10 |
| Research & Development to Revenue | 0.54 | 0.79 | 1.08 | 4.09 | 10.74 |
| SG&A to Revenue | 3.30 | 3.93 | 2.40 | 10.74 | 16.92 |
| Stock-Based Compensation to Revenue | 0.43 | 1.17 | 1.42 | 4.19 | 2.36 |
| Income Quality | 0.86 | 0.72 | 0.78 | 0.64 | 0.61 |
Currency in USD

